No Data
Galectin Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Galectin Therapeutics Analyst Ratings
H.C. Wainwright Downgrades Galectin Therapeutics(GALT.US) to Hold Rating
H.C. Wainwright Downgrades Galectin Therapeutics After MASH Trial Fails
Insider Purchase: Director at $GALT (GALT) Buys 13,469 Shares
12 Health Care Stocks Moving In Friday's Pre-Market Session